Scaling is launching, again and again.
Every new segment, market, first sales hire or raise is a launch. Scaling is launching again and again, to the same standard. That’s what I’ve done for two decades.
In pharma, the first launch isn’t the hard part. The hard part is launch number seven, in a new country, on time and to the same standard. That’s the exam a Series A company sits too: can revenue repeat without the founder?
Pharma-launch rigor. Startup speed.
Pharma proves the rigor.
J&J Innovative Medicines and Grünenthal: first-in-class, hands-on launches, multi-country sequencing, Launch Steering Committee leadership, and a replicable enterprise Launch Readiness Process.
B2B and consumer durables prove it transfers.
The same launch discipline, applied across industries and across the Americas, Europe and Asia.
Startups and SMEs prove the speed.
DragonflyAI: the strategy, and the systems that put it into motion. Live in weeks, run every month. You work with me. No handoffs.
Chair, T2B AI Roundtable. Speaker on agentic AI, go-to-market and governance.